drugset
Drugs / Yellow Fever 17DD Vaccine
last change Sep 2021 re-read 3 minutes ago

Yellow Fever 17DD Vaccine

Vaccine

Developed for
yellow fever
Investigated by
Centers for Disease Control and Prevention · Infectious Disease Institute, Kampala, Uganda · MRC/UVRI and LSHTM Uganda Research Unit · Ministry of Health, Uganda

Trials 1

today NCT03725618 · Ph 4
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03725618 Nov 2018 → Sep 2021 yellow fever Centers for Disease Control and Prevention Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Yellow Fever 17DD Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT03725618 ↗
Modality Vaccine “live attenuated vaccine based on the 17DD strain” NCT03725618 ↗
Route Subcutaneous “administered subcutaneously” NCT03725618 ↗